Life sciences
Navigating Digital Deals in Life Sciences Part 5 | Deal Structure, Terms and Series Conclusions
Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Navigating Digital Deals in Life Sciences Part 5 | Deal Structure, Terms and Series Conclusions
by Philip Whitchelo
Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Learn more ->
Navigating Digital Deals in Life Sciences Part 4 | Due Diligence
Welcome to the fourth of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Navigating Digital Deals in Life Sciences Part 4 | Due Diligence
by Philip Whitchelo
Welcome to the fourth of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Learn more ->
Navigating Digital Deals in Life Sciences Part 3 | Defining & Valuing the Asset
Welcome to the third of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Navigating Digital Deals in Life Sciences Part 3 | Defining & Valuing the Asset
by Philip Whitchelo
Welcome to the third of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Learn more ->
Navigating Digital Deals in Life Sciences Part 2 | Information Governance
Welcome to the second of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Navigating Digital Deals in Life Sciences Part 2 | Information Governance
by Philip Whitchelo
Welcome to the second of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Learn more ->
Navigating Digital Deals in Life Sciences Part 1 | Corporate Culture
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Navigating Digital Deals in Life Sciences Part 1 | Corporate Culture
by Philip Whitchelo
Welcome to the first of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them Different?" Transactions involving digital assets are an increasing focus for...
Learn more ->
Commercial real estate spotlight: life sciences
“Two roads diverged in a wood and I – I took the one less traveled by, and that has made all the difference.”1 Following on from my previous blog post - Commercial real estate reflections - history...
Commercial real estate spotlight: life sciences
by Harry Iles
“Two roads diverged in a wood and I – I took the one less traveled by, and that has made all the difference.”1 Following on from my previous blog post - Commercial real estate reflections - history...
Learn more ->
Webinar: How to maximise value & avoid failure during life sciences dealmaking
During this webinar, an expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best...
Webinar: How to maximise value & avoid failure during life sciences dealmaking
by Philip Whitchelo
During this webinar, an expert panel of life sciences dealmaking veterans from AstraZeneca and Merck, with 100 years' collective experience, share their insights on key dealmaking strategies, best...
Learn more ->